As demand for weight-loss drugs rises, states grapple with Medicaid coverage In January, the National Association of Medicaid Directors told the federal Centers for Medicare & Medicaid Services that state Medicaid departments had significant concerns over the fiscal impacts of the Biden proposal to require coverage of GLP-1s, and strongly recommend that CMS maintain the current state option to cover or not cover anti-obesity medications. But others say covering the drugs will yield long-term savings
Multiple groups have studied, characterised, and observed both compounds across in vitro, animal-model, and clinical-research contexts the combined-compound translation is not yet documented in clinical-trial-stage publications
T.RajkumarK.MurphyL
A new target trial emulation analyzed insurance claims data from over 3,500 pregnancies and found that continuation of GLP-1 RAs during the first trimester of pregnancy was not associated with a substantially increased risk for pregnancy loss, abnormal fetal growth, or major birth defects
Millions of people taking metformin for type 2 diabetes or prediabetes wonder whether adding a GLP-1 medication like semaglutide is safe
Glanbia Nutritionals 17.10
